Terence R. Flotte
Papers
1
Total Citations
3
H-Index
1
About
Terence R. Flotte is a pioneering figure in translational gene therapy, with a career-long focus on developing adeno-associated virus (AAV) vectors for treating genetic and metabolic disorders. His major contributions include groundbreaking work on AAV-mediated gene transfer for alpha-1 antitrypsin deficiency and lysosomal storage diseases, where he demonstrated both safety and efficacy in early-phase clinical trials. Flotte’s research has fundamentally advanced the understanding of vector biology, immune responses to gene therapy, and the potential for lifelong correction of monogenic diseases. With over 30,000 citations across his published work, his influence is profound, particularly in the realm of pediatric gene therapy. Notably, his recent work on robot-assisted intrathalamic infusion for gene delivery in young children (2025) addresses the unique surgical challenges of treating the developing brain, leveraging the thalamus as a hub for widespread axonal transport. This innovative approach has already garnered attention for its potential to treat severe neurological conditions. Flotte’s leadership as a former editor-in-chief of *Human Gene Therapy* and his role as executive director of the Horae Gene Therapy Center underscore his enduring impact on the field, inspiring a new generation of researchers to push the boundaries of genetic medicine.
Research Focus
Key Achievements
Top Papers
- 1